{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:12:42Z","timestamp":1757311962630,"version":"3.37.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.14310\/horm.2002.1346","type":"journal-article","created":{"date-parts":[[2014,1,31]],"date-time":"2014-01-31T15:26:28Z","timestamp":1391181988000},"page":"189-198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical Case Seminar. Peculiar prolactinomas in patients with pituitary developmental gene mutations: From an adult endocrinologist perspective"],"prefix":"10.1007","volume":"11","author":[{"given":"Mirjana","family":"Doknic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Pekic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milorad","family":"Civcic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,1]]},"reference":[{"key":"11020189_CR1","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1210\/er.2009-0008","volume":"30","author":"D Kelberman","year":"2009","unstructured":"Kelberman D, Rizzoti K, Lovell-Badge R, Robinson IC, Dattani MT, 2009 Genetic regulation of pituitary gland development in human and mouse. Endocrine Rev 30: 790\u2013892.","journal-title":"Endocrine Rev"},{"key":"11020189_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.beem.2010.10.014","volume":"25","author":"R Pfaffle","year":"2011","unstructured":"Pfaffle R, Klammt J, 2011 Pituitary transcription factors in the aetiology of combined pituitary hormone deficiency. Best Pract Res Clin Endocrinol Metab 25: 43\u201360.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"11020189_CR3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1210\/er.2010-0011","volume":"32","author":"F Castinetti","year":"2011","unstructured":"Castinetti F, Davis SW, Brue T, Camper SA, 2011 Pituitary stem cell update and potential implications for treating hypopituitarism. Endocr Rev 32: 453\u2013471.","journal-title":"Endocr Rev"},{"key":"11020189_CR4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1053\/beem.2002.0218","volume":"16","author":"S Mody","year":"2002","unstructured":"Mody S, Brown MR, Parks JS, 2002 The spectrum of hypopituitarism caused by PROP1 mutation Best Pract Res Clin Endocrinol Metab 16: 421\u2013431.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"11020189_CR5","first-page":"138","volume":"68","author":"D Kelberman","year":"2007","unstructured":"Kelberman D, Dattani M, 2007 Hypopituitarism oddities: congenital causes. Horm Res 68: Suppl 5: 138\u2013144.","journal-title":"Horm Res"},{"key":"11020189_CR6","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1210\/jc.2004-0661","volume":"89","author":"A B\u00f6ttner","year":"2004","unstructured":"B\u00f6ttner A, Keller E, Kratzsch J, et al, 2004 PROP1 mutations cause progressive deterioration of anterior pituitary function including adrenal insufficiency: a longitudinal analysis. J Clin Endocrinol Metab 89: 5256\u20135265.","journal-title":"J Clin Endocrinol Metab"},{"key":"11020189_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s12020-011-9516-8","volume":"40","author":"S Pekic","year":"2011","unstructured":"Pekic S, Doknic M, Miljic D, et al, 2011 Case seminar: a young female with acute hyponatremia and a sellar mass. Endocrine 40: 325\u2013331.","journal-title":"Endocrine"},{"key":"11020189_CR8","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1210\/jc.2003-031765","volume":"89","author":"A Voutetakis","year":"2004","unstructured":"Voutetakis A, Argyropoulou M, Sertedaki A, et al, 2004 Pituitary magnetic resonance imaging in 15 patients with Prop1 gene mutations: pituitary enlargement may originate from the intermediate lobe. J Clin Endocrinol Metab 89: 2200\u20132206.","journal-title":"J Clin Endocrinol Metab"},{"key":"11020189_CR9","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/BF03344131","volume":"29","author":"A Voutetakis","year":"2006","unstructured":"Voutetakis A, Sertedaki A, Livadas S, et al, 2006 Pituitary size fluctuation in long-term MR studies of PROP1 deficient patients: A persistent pathophysiological mechanism? J Endocrinol Invest 29: 462\u2013466.","journal-title":"J Endocrinol Invest"},{"key":"11020189_CR10","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1159\/000312700","volume":"39","author":"N Pitteloud","year":"2010","unstructured":"Pitteloud N, Durrani S, Raivio T, Sykiotis GP, 2010 Complex genetics in idiopathic hypogonadotropic hypogonadism. Front Horm Re 39: 142\u2013153.","journal-title":"Front Horm Re"},{"key":"11020189_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1365-2826.2007.01627.x","volume":"20","author":"SH Kim","year":"2008","unstructured":"Kim SH, Hu Y, Cadman S, Bouloux P, 2008 Diversity in fibroblast growth factor receptor 1 regulation: learning from the investigation of Kallmann syndrome. J Neuroendocrinol 20: 141\u2013163.","journal-title":"J Neuroendocrinol"},{"key":"11020189_CR12","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.tem.2010.01.004","volume":"21","author":"Y Hu","year":"2010","unstructured":"Hu Y, Bouloux P, 2010 Novel insights in FGFR1 regulation: lessons from Kallmann syndrome. Trends Endocrinol Metab 21: 385\u2013393.","journal-title":"Trends Endocrinol Metab"},{"key":"11020189_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/ng1122","volume":"33","author":"C Dod\u00e9","year":"2003","unstructured":"Dod\u00e9 C, Levilliers J, Dupont JM, et al, 2003 Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet 33: 463\u2013465.","journal-title":"Nat Genet"},{"key":"11020189_CR14","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1073\/pnas.0600962103","volume":"103","author":"N Pitteloud","year":"2006","unstructured":"Pitteloud N, Acierno JS Jr, Meysing A, et al, 2006 Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci USA 103: 6281\u20136286.","journal-title":"Proc Natl Acad Sci USA"},{"key":"11020189_CR15","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1056\/NEJMoa066494","volume":"357","author":"T Raivio","year":"2007","unstructured":"Raivio T, Falardeau J, Dwyer A, et al, 2007 Reversal of idiopathic hypogonadotropic hypogonadism. N Engl J Med 357: 863\u2013873.","journal-title":"N Engl J Med"},{"key":"11020189_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1046\/j.1365-2265.2001.01150-3.x","volume":"54","author":"R Quinton","year":"2001","unstructured":"Quinton R, Beirne P, Bouloux P, Stanhope R, Conway G, 2001 Routine neuroimaging in classical isolated gonadotropic deficiency is of limited clinical value. Clin Endocrinol (Oxf) 54: 127\u2013129.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"11020189_CR17","doi-asserted-by":"crossref","unstructured":"Raivio T, Avbelj M, McCabe MJ, et al, 2012 Genetic overlap in Kallmann Syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia. J Clin Endocrinol Metab 97, Feb 8 (Epub ahead of print).","DOI":"10.1210\/jc.2011-2938"},{"key":"11020189_CR18","first-page":"2012","volume":"82","author":"E Delgrange","year":"1997","unstructured":"Delgrange E, Trouillas J, Maiter D, Donchier J, Tourniaire J, 1997 Sex-related difference in the growth of prolactinomas: a clinical and proliferation study. J Clin Endocrinol Metab 82: 2012\u20132017.","journal-title":"J Clin Endocrinol Metab"},{"key":"11020189_CR19","first-page":"505","volume":"3","author":"M Doknic","year":"2004","unstructured":"Doknic M, Pekic S, Djurovic M, Zivkovic V, Popovic V, 2004 Multiple pituitary hormone deficiency (MPHD) associated with normal height, absent puberty and obesity. Pediatr Endocrinol Rev 1: Suppl 3: 505\u2013507.","journal-title":"Pediatr Endocrinol Rev 1: Suppl"},{"key":"11020189_CR20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s12020-011-9493-y","volume":"40","author":"H Iwayama","year":"2011","unstructured":"Iwayama H, Kamijo T, Ueda N, 2011 Hyperinsulinemia may promote growth without GH in children after resection of suprasellar tumors. Endocrine 40: 130\u2013133.","journal-title":"Endocrine"},{"key":"11020189_CR21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1046\/j.1365-2265.2003.01805.x","volume":"59","author":"L Lazar","year":"2003","unstructured":"Lazar L, Dan S, Phillip M, 2003 Growth without growth hormone: growth pattern and final height of five patients with idiopathic combined pituitary hormone deficiency. Clin Endocrinol (Oxf) 59: 82\u201388.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"11020189_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1054\/ghir.2001.0204","volume":"11","author":"M Pavlou","year":"2001","unstructured":"Pavlou M, Tsatsoulis A, Efstathiadou Z, Bitsis S, Papadopoulou ZL, 2001 A study of the growth-promoting and metabolic effects of growth hormone (GH) in a patient with the \u201cgrowth without GH\u201d syndrome. Growth Horm IGF Res 11: 225\u2013230.","journal-title":"Growth Horm IGF Res"},{"key":"11020189_CR23","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1210\/jc.2009-1743","volume":"95","author":"V Rochira","year":"2010","unstructured":"Rochira V, Zirilli L, Maffei L, et al, 2010 Tall stature without growth hormone: four male patients with aromatase deficiency. J Clin Endocrinol Metab 95: 1626\u20131633.","journal-title":"J Clin Endocrinol Metab"},{"key":"11020189_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1046\/j.1365-2265.2002.01550.x","volume":"57","author":"A Aroyo","year":"2002","unstructured":"Aroyo A, Permasetti V, Vasilyev V, Amato S, Yen S, Mellon P, 2002 A unique case of combined pituitary hormone deficiency caused by PROP1 gene mutation (R120C) associated with normal height. Clin Endocrinol (Oxf) 57: 283\u2013291.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"11020189_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1046\/j.1365-2265.2002.01554.x","volume":"57","author":"M Dattani","year":"2002","unstructured":"Dattani M, 2002 GH deficiency might be associated with normal height in PROP1 deficiency. Clin Endocrinol (Oxf) 57: 157\u2013158.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"11020189_CR26","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1046\/j.1365-2265.1998.00590.x","volume":"49","author":"A Tiulpakov","year":"1998","unstructured":"Tiulpakov A, Mazerkina N, Brook C, Hindmarsh P, Peterkova V, Gorelyskev S, 1998 Growth in children with craniopharyngioma following surgery. Clin Endocrinol (Oxf) 49: 733\u2013738.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"11020189_CR27","doi-asserted-by":"publisher","first-page":"4529","DOI":"10.1210\/jcem.86.9.7811","volume":"86","author":"S Vallette-Kasic","year":"2001","unstructured":"Vallette-Kasic S, Barlier A, Teinturier C, et al, 2001 PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency. J Clin Endocrinol Metab 86: 4529\u20134535.","journal-title":"J Clin Endocrinol Metab"},{"key":"11020189_CR28","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-2265.2006.02617.x","volume":"65","author":"MC Lemos","year":"2006","unstructured":"Lemos MC, Gomest L, Bastos M, et al, 2006 PROP1 gene analysis in Portuguese patients with combined pituitary hormone deficiency. Clin Endocrinol (Oxf) 65: 479\u2013485.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"11020189_CR29","first-page":"653","volume":"22","author":"A Zygmunt-Gorska","year":"2009","unstructured":"Zygmunt-Gorska A, Starzyk J, Adamek D, et al, 2009 Pituitary enlargement in patients with PROP 1gene inactivating mutation represents cystic hyperplasia of the intermediate pituitary lobe. Histopathology and over 10 years follow-up of two patients. J Pediatr Endocrinol Metab 22: 653\u2013660.","journal-title":"Histopathology and over 10 years follow-up of two patients. J Pediatr Endocrinol Metab"},{"key":"11020189_CR30","unstructured":"Parks JS, Brown MR, Baumach I, Sanchez JC, Stanley CA, Gianella-Neto D, 1998 Natural history and molecular mechanism of hypopituitarism with large sella turcica. 80th Annual Meeting of the Endocrine Society, 470."},{"key":"11020189_CR31","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1210\/jc.2010-1048","volume":"96","author":"P Freda","year":"2011","unstructured":"Freda P, Beckers A, Katznelson L, et al, 2011 Endocrine Society Pituitary incidentaloma: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 96: 894\u2013904.","journal-title":"J Clin Endocrinol Metab"},{"key":"11020189_CR32","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/BF03345305","volume":"27","author":"S Bolu","year":"2004","unstructured":"Bolu S, Tasar M, Uckaya G, Gonul E, Deniz F, Ozdemir IC, 2004 Increased abnormal pituitary findings on magnetic resonance in patients with male hypogonadotropic hypogonadism. J Endocrinol Invest 27: 1029\u20131033.","journal-title":"J Endocrinol Invest"},{"key":"11020189_CR33","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/humu.21606","volume":"32","author":"KS Atazoglou","year":"2011","unstructured":"Atazoglou KS, Andoniadou CL, Kelberman D, et al, 2011 SOX2 haploinsufficiency is associated with slow progressing hypothalamo-pituitary tumours. Hum Mutat 32: 1376\u20131380.","journal-title":"Hum Mutat"},{"key":"11020189_CR34","doi-asserted-by":"publisher","first-page":"11482","DOI":"10.1073\/pnas.1101553108","volume":"108","author":"C Gaston-Massuet","year":"2011","unstructured":"Gaston-Massuet C, Andoniadou CL, Signore M, et al, 2011 Increased Wingless (Wnt) signaling in pituitary progenitor\/stem cells gives rise to pituitary tumors in mice and humans. Proc Natl Acad Sci USA 108: 11482\u201311487.","journal-title":"Proc Natl Acad Sci USA"},{"key":"11020189_CR35","doi-asserted-by":"publisher","first-page":"e234","DOI":"10.1111\/j.1365-2605.2011.01157.x","volume":"34","author":"LH Looijenga","year":"2011","unstructured":"Looijenga LH, Gillis AJ, Stoop H, Biermann K, Oosterhuis JW, 2011 Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance. Int J Androl 34 (4 Pt 2): e234\u201351. doi: 10.1111\/j.1365\u20132605.2011.01157.x. Epub 2011 May 12.","journal-title":"Int J Androl"},{"key":"11020189_CR36","first-page":"562","volume":"118","author":"K Kovacs","year":"1994","unstructured":"Kovacs K, Stefaneanu L, Ezzat S, Smyth HS, 1994 Prolactin-promoting pituitary adenoma in male-to-female transsexual patient with protracted estrogen administration. A morphologic study. Arch Pathol Lab Med 118: 562\u2013565.","journal-title":"A morphologic study. Arch Pathol Lab Med"},{"key":"11020189_CR37","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/15275","volume":"5","author":"AP Heaney","year":"1999","unstructured":"Heaney AP, Horowitz GA, Wang Z, Singson R, Melmed S, 1999 Early involvement of estrogen induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat Med 5: 1317\u20131321.","journal-title":"Nat Med"},{"key":"11020189_CR38","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1158\/1078-0432.CCR-07-2003","volume":"14","author":"X Zhu","year":"2008","unstructured":"Zhu X, Asa SL, Ezzat S, 2008 Fibroblast growth factor 2 and estrogen control the balance of histone 3 modifications targeting MAGE-A3 in pituitary neoplasia. Clin Cancer Res 14: 1984\u20131996.","journal-title":"Clin Cancer Res"},{"key":"11020189_CR39","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1507\/endocrj.K08E-082","volume":"55","author":"S Ezzat","year":"2008","unstructured":"Ezzat S, 2008 Epigenetic control in pituitary tumors. Endocrine J 55: 951\u2013957.","journal-title":"Endocrine J"},{"key":"11020189_CR40","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1677\/JME-09-0009","volume":"42","author":"KJ Dudley","year":"2009","unstructured":"Dudley KJ, Revill K, Clayton RN, Farrell WE, 2009 Pituitary tumours: all silent on the epigenetics front. J Mol Endocrinol 42: 461\u2013468.","journal-title":"J Mol Endocrinol"},{"key":"11020189_CR41","first-page":"83","volume":"78","author":"L Stefaneanu","year":"1994","unstructured":"Stefaneanu L, Kovacs K, Hovarth E, et al, 1994 In situ hybridization study of estrogen receptor messenger ribonucleic acid in human adenohypophysial cells and pituitary adenomas. J Clin Endocrinol Metab 78: 83\u201388.","journal-title":"J Clin Endocrinol Metab"},{"key":"11020189_CR42","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1677\/ERC-06-0008","volume":"14","author":"K Hemminki","year":"2007","unstructured":"Hemminki K, Forsti A, Ji J, 2007 Incidence and familial risks in pituitary adenoma and associated tumors. Endocrine-Related Cancer 14: 103\u2013109.","journal-title":"Endocrine-Related Cancer"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.14310\/horm.2002.1346.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.14310\/horm.2002.1346\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.14310\/horm.2002.1346.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T15:36:13Z","timestamp":1739115373000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.14310\/horm.2002.1346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["11020189"],"URL":"https:\/\/doi.org\/10.14310\/horm.2002.1346","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"type":"print","value":"1109-3099"},{"type":"electronic","value":"2520-8721"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"11 October 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}